Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The leading three animal health distributors in the US could be facing more of a challenge from smaller competitors as their market share dipped in the last year.
In this latest podcast, Animal Pharm editor Joseph Harvey speaks to Scott Brown, vice president of external innovation at Zoetis. The podcast below covers the company's blueprint for external collaboration, particularly with human health businesses.
Zoetis has confirmed its plans to expand its global manufacturing and supply facility in Charles City, Iowa.
VitamFero has partnered with a fellow French company to establish a master seed bank for its Toxo KO ovine toxoplasmosis vaccine strain.
Ceva Santé Animale is holding a US summit this week to present and discuss its new technology poultry vaccines and indicate further innovation it expects to see in the future.
The search for a vaccine to prevent the deadly Middle East respiratory syndrome (MERS) has received a boost with the granting of new funding for the University of Saskatchewan in Canada.
The US animal health industry is an "integral part of the US economy" worth around $9.9 billion in revenues, according to a new report from the Animal Health Institute (AHI).
A researcher at Arizona State University (ASU) has been awarded $6.4 million to test a preventative canine cancer vaccine.
The European Platform for the Responsible Use of Medicines in Animals (EPRUMA) has called for a One Health approach to vaccines in the EU.
Stonehaven Incubate has been launched to translate innovation in the human health space into new animal health companies. Animal Pharm Joseph Harvey editor spoke to the firm's chief executive Mark Heffernan about this new home for start-ups.
The US FDA has issued draft guidance on proprietary names for new animal drugs.
A new Latin America-led body is aiming to improve shrimp farming by implementing higher standards, full traceability with zero use of antibiotics.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.